Bimzelx Data Show 3-Year Pain And Tunnel Resolution Gains in HS
01 Nov 2025 //
PR NEWSWIRE
Amgen Announces 2025 Fourth Quarter Dividend
01 Nov 2025 //
PR NEWSWIRE
EU Okays Alexion’s Koselugo For Adults With Neurofibromatosis
01 Nov 2025 //
INDPHARMAPOST
Calluna Pharma Receives FDA Orphan Drug Designation For CAL101
01 Nov 2025 //
BUSINESSWIRE
Nxera Pharma Gets Partial Amendment for Quviviq Manufacturing
01 Nov 2025 //
GLOBENEWSWIRE
Lilly Refines Pain Pipeline Again, Scrapping Mid-Stage Program
01 Nov 2025 //
BIOSPACE
Metsera Issues Statement in Response to Litigation
01 Nov 2025 //
PR NEWSWIRE
Boehringer Returns to Kyowa with €640 M Pact for Autoimmune Drug
30 Oct 2025 //
GLOBENEWSWIRE
BMS Removes 2 Clinical Programs From Pipeline
30 Oct 2025 //
FIERCE BIOTECH
Drugs In Development
Market Intel

Market Place
Sourcing Support